A 92-year-old woman with normal systolic function had recently begun using the newly approved phosphodiesterase III inhibitor cilostazol when she was admitted with lower-extremity pain. Cilostazol is

PubMed Central30

Physicians' responses of the top 10 frequent inappropriate drug prescriptions when receiving hard-stop warnings. a

处方行为干预

药物安全预警

aAt the points of the first (June, 2010), second (July, 2010), twelfth (May, 2011) and fifteenth (August, 2011) months after intervention. bFor example, 0.5 tab twice daily changed to 1 tab once daily

NIAID Data Ecosystem70

Safety outcomes in the patients who received an injection of the investigational product.

临床试验安全性评估

药物不良反应监测

Safety outcomes in the patients who received an injection of the investigational product.

Figshare2019-12-10 更新50